133 related articles for article (PubMed ID: 38309587)
1. Disease and toxicity outcomes for a modern cohort of patients with squamous cell carcinoma of cutaneous origin involving the parotid gland: Comparison of volumetric modulated arc therapy and pencil beam scanning proton therapy.
Zarinshenas R; Campbell P; Sun K; Molitoris JK; Patel AN; Witek ME; Cullen KJ; Mehra R; Hatten KM; Moyer KF; Taylor RJ; Vakharia KT; Wolf JS; Ferris MJ
Radiother Oncol; 2024 Apr; 193():110112. PubMed ID: 38309587
[TBL] [Abstract][Full Text] [Related]
2. Parotid and neck metastases from cutaneous squamous cell carcinoma of the head and neck.
Khurana VG; Mentis DH; O'Brien CJ; Hurst TL; Stevens GN; Packham NA
Am J Surg; 1995 Nov; 170(5):446-50. PubMed ID: 7485729
[TBL] [Abstract][Full Text] [Related]
3. Proton Beam Therapy for Locally Advanced Head and Neck Tumors: An Analysis of Dosimetric and Clinical Outcomes.
Sheikh S; Kharouta MZ; Pidikiti R; Damico NJ; Choi S; Dorth JA; Mansur DB; Machtay MX; Yao M; Bhatt AD
Am J Clin Oncol; 2022 Feb; 45(2):81-87. PubMed ID: 35073281
[TBL] [Abstract][Full Text] [Related]
4. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland.
O'Brien CJ; McNeil EB; McMahon JD; Pathak I; Lauer CS; Jackson MA
Head Neck; 2002 May; 24(5):417-22. PubMed ID: 12001070
[TBL] [Abstract][Full Text] [Related]
5. Comparative cohort study of volumetric modulated arc therapy for squamous cell cancer of unknown primary in the head and neck-Involved neck only versus mucosal irradiation.
Poon WY; Thomson M; McLoone P; Wilson C; Crosbie R; Schipani S; Grose D; James A; Lamb C; Rizwanullah M; Campbell F; Easton F; Paterson C
Clin Otolaryngol; 2020 Nov; 45(6):847-852. PubMed ID: 32501648
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
7. Real-life assessment of Volumetric Modulated Arc Therapy (VMAT) toxicity in Head and Neck Squamous Cell Carcinoma (HNSCC) treatment.
Moncharmont C; Vallard A; Mengue Ndong S; Guy JB; Saget C; Méry B; Langrand-Escure J; de Laroche G; Goyet D; Prades JM; Fournel P; Magné N
Acta Otolaryngol; 2016; 136(2):181-8. PubMed ID: 26503806
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy for cutaneous head and neck cancer and parotid tumours: a prospective investigation of treatment-related acute swallowing and toxicity patterns.
Moroney LB; Helios J; Ward EC; Crombie J; Burns CL; Yeo SQ; Pelecanos A; Spurgin AL; Blake C; Kenny L; Chua B; Hughes BGM
Support Care Cancer; 2019 Feb; 27(2):573-581. PubMed ID: 30019149
[TBL] [Abstract][Full Text] [Related]
9. Radiation therapy for cutaneous squamous cell carcinoma involving the parotid area lymph nodes: dose and volume considerations.
Chen AM; Grekin RC; Garcia J; Bucci MK; Margolis LW
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1377-80. PubMed ID: 17689882
[TBL] [Abstract][Full Text] [Related]
10. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST
J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505
[TBL] [Abstract][Full Text] [Related]
11. Risk Factors for Poor Survival Outcomes in Parotid Metastatic Cutaneous Squamous Cell Carcinoma.
Laxague F; Dzioba A; Jasani D; Warner A; Palma DA; Lang P; Venkatesan V; Read N; Nichols AC; Fung K; Yoo J; Mendez A; MacNeil SD
Laryngoscope; 2023 May; 133(5):1163-1168. PubMed ID: 35880608
[TBL] [Abstract][Full Text] [Related]
12. Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral radiation.
Romesser PB; Cahlon O; Scher E; Zhou Y; Berry SL; Rybkin A; Sine KM; Tang S; Sherman EJ; Wong R; Lee NY
Radiother Oncol; 2016 Feb; 118(2):286-92. PubMed ID: 26867969
[TBL] [Abstract][Full Text] [Related]
13. Can dose reduction to one parotid gland prevent xerostomia?--A feasibility study for locally advanced head and neck cancer patients treated with intensity-modulated radiotherapy.
Anand AK; Jain J; Negi PS; Chaudhoory AR; Sinha SN; Choudhury PS; Kumar R; Munjal RK
Clin Oncol (R Coll Radiol); 2006 Aug; 18(6):497-504. PubMed ID: 16909975
[TBL] [Abstract][Full Text] [Related]
14. Incidence of cervical node involvement in metastatic cutaneous malignancy involving the parotid gland.
O'Brien CJ; McNeil EB; McMahon JD; Pathak I; Lauer CS
Head Neck; 2001 Sep; 23(9):744-8. PubMed ID: 11505484
[TBL] [Abstract][Full Text] [Related]
15. A dosimetric comparison of the use of equally spaced beam (ESB), beam angle optimization (BAO), and volumetric modulated arc therapy (VMAT) in head and neck cancers treated by intensity modulated radiotherapy.
Leung WS; Wu VWC; Liu CYW; Cheng ACK
J Appl Clin Med Phys; 2019 Nov; 20(11):121-130. PubMed ID: 31593367
[TBL] [Abstract][Full Text] [Related]
16. Parotid Gland Metastases of Cutaneous Squamous Cell Carcinoma of the Head: Occult Metastases Occurrence and Their Late Manifestation.
Horakova Z; Starek I; Zapletalova J; Salzman R
Int J Clin Pract; 2024; 2024():5525741. PubMed ID: 38410673
[TBL] [Abstract][Full Text] [Related]
17. Parotidectomy and neck dissection in locally advanced and relapsed cutaneous squamous cell carcinoma of the head and neck region.
Melo GM; Guilherme LH; Palumbo MDN; Rosano M; Neves MCD; Callegari FM; Abrahao M; Cervantes O
Braz J Otorhinolaryngol; 2022; 88 Suppl 4(Suppl 4):S152-S162. PubMed ID: 35042657
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced esophageal squamous cell carcinoma.
Hirano Y; Onozawa M; Hojo H; Motegi A; Zenda S; Hotta K; Moriya S; Tachibana H; Nakamura N; Kojima T; Akimoto T
Radiat Oncol; 2018 Feb; 13(1):23. PubMed ID: 29426342
[TBL] [Abstract][Full Text] [Related]
19. Metastatic cutaneous squamous cell carcinoma to the parotid: Adjuvant radiotherapy and treatment outcomes.
Hu M; Kim ANH; Emeto TI; Collins M; Chopping A; Lin C
J Med Radiat Sci; 2023 Jun; 70(2):161-170. PubMed ID: 36790039
[TBL] [Abstract][Full Text] [Related]
20. Recovery of Salivary Function: Contralateral Parotid-sparing Intensity-modulated Radiotherapy versus Bilateral Superficial Lobe Parotid-sparing Intensity-modulated Radiotherapy.
Miah AB; Gulliford SL; Morden J; Newbold KL; Bhide SA; Zaidi SH; Hall E; Harrington KJ; Nutting CM
Clin Oncol (R Coll Radiol); 2016 Sep; 28(9):e69-e76. PubMed ID: 26994893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
